Publications: Our research

Filter
Research Area
Technology
Resource type
Category
135 results found
Mar 16, 2024
Publication
Novavax led
Vaccine
COVID-19, Matrix-M™ adjuvant
Benefit–risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373)
Jonathan Fix, T. Christopher Mast, Katherine Smith, et al.
Mar 6, 2024
Publication
Novavax led
The Lancet Infectious Diseases
COVID-19, Matrix-M™ adjuvant
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial
Chijioke Bennett, Wayne Woo, Mark Bloch, et al.
Feb 19, 2024
Publication
Novavax led
Clinical Infectious Diseases
COVID-19, Matrix-M™ adjuvant
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-cov2373 Vaccine
Dean Follmann, Allyson Matej, Michael P. Fay, et al.
Feb 15, 2024
Publication
Novavax led
Vaccine
COVID-19, Matrix-M™ adjuvant
Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine
Seth Toback, Anthony M. Marchese, Brandy Warren, et al.
Feb 12, 2024
Publication
Novavax led
Journal of Infection
COVID-19, Matrix-M™ adjuvant
Altered IgG4 Antibody Response to Repeated mRNA versus Recombinant Protein SARS-CoV-2 Vaccine
Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark , et al.
Feb 9, 2024
Publication
Novavax led
Pre-print
COVID-19, Matrix-M™ adjuvant
Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters
Jacco Boon, Nadia Soudani, Traci Bricker, et al.
Feb 8, 2024
Publication
Collaborative
bioRxiv
Malaria, Matrix-M™ adjuvant
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Barnabas G Williams, Lloyd D.W King, David Pulido, et al.
Feb 2, 2024
Publication
Novavax led
Journal of Virology
COVID-19, Matrix-M™ adjuvant
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters
Traci L. Bricker , Astha Joshi , Nadia Soudani, et al.
Jan 30, 2024
Publication
Collaborative
The Journal of Clinical Investigation
Malaria, Matrix-M™ adjuvant
A randomized first-in-human Phase 1 trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults
B. Alfred Tiono, Jordan Plieskatt, Alphonse Ouedraogo, et al.
Jan 24, 2024
Publication
Novavax led
Vaccine
COVID-19, Matrix-M™ adjuvant
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States
Kyle Paret, Hadi Beyhaghi, William L. Herring, et al.